Cullinan Therapeutics CGEM
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 5.93 | 109.85 | -0.77 | -55,595 | -51 | |
| 2025Q2 | 7.53 | 108.20 | -1.07 | -75,798 | -70 | |
| 2025Q1 | 7.57 | 113.39 | -0.74 | -54,996 | -49 | |
| 2024Q4 | 12.18 | 115.82 | -0.74 | -55,048 | -48 | |
| 2024Q3 | 16.74 | 120.45 | -0.61 | -48,855 | -41 | |
| 2024Q2 | 17.44 | 119.03 | -0.68 | -50,027 | -42 | |
| 2024Q1 | 17.04 | 115.13 | -0.75 | -42,989 | -37 | |
| 2023Q4 | 10.19 | 114.62 | -0.06 | -45,485 | -24 | |
| 2023Q3 | 9.05 | 115.47 | -0.91 | -45,243 | -39 | |
| 2023Q2 | 10.76 | 116.73 | 6.48 | -0.82 | -37,605 | -32 |
| 2023Q1 | 10.23 | 107.94 | 6.16 | -1.42 | -62,756 | -58 |
| 2022Q4 | 10.55 | 112.65 | 4.58 | -0.58 | -32,608 | -27 |
| 2022Q3 | 12.82 | 108.58 | 5.54 | -0.55 | -29,766 | -25 |
| 2022Q2 | 12.82 | 46.37 | 5.08 | 3.78 | 239,679 | 175 |
| 2022Q1 | 10.47 | 100.61 | -0.27 | -32,657 | -12 | |
| 2021Q4 | 15.43 | 100.41 | -0.76 | -34,347 | -33 | |
| 2021Q3 | 22.57 | 100.64 | -0.39 | -18,375 | -17 | |
| 2021Q2 | 25.75 | 101.00 | -0.37 | -16,604 | -16 | |
| 2021Q1 | 41.67 | 96.69 | 0.00 | 1,372 | 0 | |
| 2020Q4 | 100.23 | -1.39 | -29,173 | -28 |